SATB1 Mediates Long-Range Chromatin Interactions: A Dual Regulator of Anti-Apoptotic BCL2 and Pro-Apoptotic NOXA Genes by Yin Yang et al.
RESEARCH ARTICLE
SATB1 Mediates Long-Range Chromatin
Interactions: A Dual Regulator of Anti-
Apoptotic BCL2 and Pro-Apoptotic NOXA
Genes
Yin Yang1,2, ZongdanWang1,2, Luan Sun1,2, Lipei Shao1,2, Nan Yang1,2, Dawei Yu1,2,
Xin Zhang3, Xiao Han1, Yujie Sun1,2,4*
1 Key Laboratory of Human Functional Genomics of Jiangsu Province, Nanjing medical University, Nanjing,
PR China, 2 Department of Cell Biology, Nanjing Medical University, Nanjing, PR China, 3 Department of
Physiology and Stephenson Cancer Center, University of Oklahoma Health Sciences Center, University of
Oklahoma, Norman, Oklahoma, United States of America, 4 Collaborative Innovation Center for Cancer
Personalized Medicine, Jiangsu Key Lab of Cancer Biomarkers, Prevention & Treatment, Cancer Center,
Nanjing Medical University, Nanjing, PR China
* yujiesun@njmu.edu.cn
Abstract
Aberrant expression of special AT-rich binding protein 1 (SATB1), a global genomic orga-
nizer, has been associated with various cancers, which raises the question of how higher-
order chromatin structure contributes to carcinogenesis. Disruption of apoptosis is one of
the hallmarks of cancer. We previously demonstrated that SATB1 mediated specific long-
range chromosomal interactions between the mbr enhancer located within 3’-UTR of the
BCL2 gene and the promoter to regulate BCL2 expression during early apoptosis. In the
present study, we used chromosome conformation capture (3C) assays and molecular
analyses to further investigate the function of the SATB1-mediated higher-order chromatin
structure in co-regulation of the anti-apoptotic BCL2 gene and the pro-apoptotic NOXA
gene located 3.4Mb downstream on Chromosome 18. We demonstrated that the mbr
enhancer spatially juxtaposed the promoters of BCL2 and NOXA genes through SATB1-
mediated chromatin-loop in Jurkat cells. Decreased SATB1 levels switched the mbr-BCL2
loop to mbr-NOXA loop, and thus changed expression of these two genes. The SATB1-
mediated dynamic switch of the chromatin loop structures was essential for the cooperative
expression of the BCL2 and NOXA genes in apoptosis. Notably, the role of SATB1 was spe-
cific, since inhibition of SATB1 degradation by caspase-6 inhibitor or caspase-6-resistant
SATB1 mutant reversed expression of BCL-2 and NOXA in response to apoptotic stimula-
tion. This study reveals the critical role of SATB1-organized higher-order chromatin struc-
ture in regulating the dynamic equilibrium of apoptosis-controlling genes with antagonistic
functions and suggests that aberrant SATB1 expression might contribute to cancer devel-
opment by disrupting the co-regulated genes in apoptosis pathways.
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Introduction
Special AT-rich binding protein 1 (SATB1) is a global genomic organizer that integrates
higher-order chromatin organization with regulation of gene expression [1]. It can recruit
chromatin-remodeling complexes to the anchored sites, and thereby regulates expression of a
number of genes over long distance of chromatin [2]. SATB1 is primarily and highly expressed
in thymocytes, and is required for thymocyte development [3] and the activation of Th2 cells
[4]. In addition, SATB1 participates in X-chromosome inactivation [5], development of the
epidermis and epidermal differentiation [6], differentiation of embryonic stem cells [7], and
cortical development [8]. In recent years, aberrant expression of SATB1 has been associated
with various cancers, including breast [9], hepatocellular [10], prostate and others [11]. Abnor-
mal SATB1 was also positively correlated with prognostic and pathological properties in breast
cancer[12], cutaneous malignant melanoma[13], and gastric cancer [14]. Recent studies in cells
with stable or transient knockdown or ectopic overexpression of SATB1 have further empha-
sized the functional relevance of SATB1 to carcinogenesis [15] and multidrug resistance in can-
cer cells [14,16]. These observations raised interesting questions of whether and how
SATB1-organized higher-order chromatin structure contributes to cancer development.
Disruption of apoptosis is a hallmark of cancer that reinforces tumorigenesis and resistance
to cytotoxic cancer therapies [17]. Members of the Bcl-2 family are critical regulators of apo-
ptosis. The intrinsic pathway of apoptosis is governed by the balance between opposing roles of
the Bcl-2 protein family, which consists of both pro-apoptotic proteins and anti-apoptotic pro-
teins. These proteins function as ‘life/death switches’ to determine whether the apoptosis path-
way should be activated, by integrating diverse inter- and intracellular cues. The Bcl-2 anti-
apoptotic proteins maintain equilibrium by holding the pro-apoptotic proteins in check, while
induction of the BH3-only pro-survival proteins results in inactivation of the anti-apoptotic
proteins, triggering the pro-apoptotic proteins Bax and Bak [18]. Thus, the cell’s fate to
undergo apoptosis is determined by interactions between anti-apoptotic proteins and pro-apo-
ptotic proteins. High expression of anti-apoptotic proteins or low expression of pro-apoptotic
proteins has been observed in many types of cancer cells [19–21]. These findings highlight the
critical role of cooperatively regulating expression of both groups of proteins to maintain the
dynamic balance in cell fate decision. Although how these two groups of proteins interact in
response to apoptotic stimulation has been extensively studied, little is known about the mech-
anism of how expression of anti-apoptotic and pro-apoptotic proteins was cooperatively regu-
lated within cells.
Proto-oncogene BCL2 encodes BCL2 anti-apoptotic protein, a key regulator of apoptosis
[22]. Our previous study has found that the major breakpoint region (mbr) located within 3’-
UTR of the BCL2 gene is an enhancer element that contains an SATB1 binding sequence
[23,24]. SATB1 is able to regulate BCL2 transcription by mediating specific long-range chro-
mosomal interaction between the mbr enhancer and BCL2 promoter during the early apoptotic
response of Jurkat cells [25]. This finding established a functional link between SATB1-orga-
nized higher-order chromatin structure and regulation of the apoptosis pathway for the first
time. Our further analyses with 3C assays revealed that the promoter of the NOXA gene that is
3.4Mb downstream of the BCL2 gene on Chromosome 18 also physically interacted with the
mbr enhancer, suggesting that the NOXA gene is targeted by the mbr enhancer. Consistently,
bioinformatic analysis revealed that the NOXA gene promoter contained SATB1 binding
sequences, indicating a potential functional role of SATB1 in the regulation of NOXA
expression.
The NOXA gene encodes NOXA, a BH3-only pro-apoptotic protein that functions as sensi-
tizer to neutralize anti-apoptotic BCL2 family proteins [26]. Our primary hypothesis was that
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SATB1 might cooperatively regulate expression of the anti-apoptotic BCL2 and pro-apoptotic
NOXA genes to participate in the control of apoptosis. Aberrant SATB1 expression could dis-
rupt apoptosis by disturbing the balance between anti-apoptotic and pro-apoptotic genes, and
thus contribute to cancer development. To test this hypothesis, we focused on two questions:
1) Whether SATB1-mediated long-range chromatin conformation is involved in the regulation
of cooperative expression of the BCL2 and NOXA genes, and 2) whether altered SATB1
expression changes the cellular apoptotic response by switching the balance between BCL2 and
NOXA.
Materials and Methods
Cell culture and induction of apoptosis
Human T lymphoid cell line Jurkat which is kindly supplied by Dr. Krontiris’ Laboratory at
City of Hope National Medical Center in Los Angeles, USA were maintained in RPMI 1640
medium supplemented with 10% FBS, 10 mMHEPES, 100unit/ml penicillin and 100mg/ml
streptomycin and cultured at 37°C in a humidified atmosphere of 5% CO2. Cells were passaged
every 2–3 days for exponential growth. For apoptosis assay, Jurkat cells were exposed to 5μM
camptothecin and the equal volume of DMSO as the vehicle control. In another assay, Jurkat
cells were preincubated with 10μMZ-VEID-fmk for 30 min for prevention the influence of
protease then induced Apoptosis.
Knockdown SATB1 by RNAi in Jurkat cells
SATB1-specific sh-RNA plasmids were prepared as described in our previous article [24]. The
SATB1 shRNA sequence was: 5’-GTCCACCTTGTCTTCTCTC-3’. The non-specific shRNA
sequence was: 5’-ACGTGACACGTTCGGAGAA-3’. Jurkat cells were transiently transfected
with SATB1 interference plasmids or control plasmids using electroporator. The extent of
shRNA-mediated inhibition of SATB1 and its effect on BCL2 and NOXA expression were eval-
uated by Western blot analysis and RT-RCR, respectively.
Western blot analysis
Cellular protein was isolated using lysis buffer (50 mM Tris, pH7.4, 0.5% NP-40 and 0.01%
SDS) containing protease inhibitors. After boiling for 5min in loading buffer, equal amounts
(30μg/lane) of proteins were fractionated on SDS-PAGE gels and transferred to polyvinylidene
difluoride membranes. Non-specific protein interactions were blocked by incubation in 5%
nonfat dry milk in TST buffer (50 mM Tris-HCl, 150mMNaCl, 0.05% Tween 20, and pH7.6)
at room temperature for 1h. Membranes were then incubated with anti-SATB1 and anti-β-
Actin antibody (Sigma) in fresh blocking buffer at 4°C overnight. After washing with PBS con-
taining 0.1% (v/v) Tween20, the membranes were incubated with peroxidase-conjugated indi-
vidual secondary antibodies for 1h at room temperature. The blots were developed with ECL
reagent (Amersham Biosciences). Prestained markers (NEB) were used as internal molecular
weight standards.
RNA isolation and real-time RCR
Total RNA was isolated with Trizol reagent (Invitrogen) according to the manufacturer’s pro-
tocol. cDNA was synthesized from total RNA (1μg) using applied biosystem cDNA Synthesis
Kit according to the Manufacturer’s instructions. The reaction was incubated at 25°C for 10
min, then applied to 37°C for 2 hour, and finally 85°C for 5min. The reactions were stored at
-20°C before use. The real-time PCR amplification conditions were 95°C for 10 min, followed
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by 40 cycles of denaturation at 95°C for 15 s, annealing at 60°C for 1 min. Primers are listed in
supporting information: S1 Table
Generation of caspase-6 resistant mutant SATB1 expression vector
To construct the plasmid SATB1-D254A (aspartate mutant to alanine at position 254 in the
human SATB1 primary sequence) which is resistant to caspase-6 cleavage, the SATB1 overex-
pression plasmid pEGFP-C1-SATB1 (generous gifts from Dr. Krontiris laboratory) was used
by using the QuikChange1 Site-Directed Mutagenesis Kit (Stratagene). The primer is as fol-
lows with the mutated bases in underline: 5’-GATATGATGGTTGAAATGGCTAGTCTTTC
TGAGCTATC-3’. Plasmid was confirmed by sequencing (BGI).
Assay for apoptosis
Apoptosis assays were performed using two Apoptosis Detection Kits (Keygentech) according
to the manufacturer’s instructions. Briefly, cells were collected and washed twice with PBS,
gently resuspended in binding buffer. Annexin V-FITC and propidium iodide (PI) were then
added and incubated in the dark for 15min at room temperature, followed by immediate analy-
sis on FACScan (Becton Dickinson). Another apoptosis detection kit is Annexin V-PE/7-AAD,
and the manufacture instruction is similar to the protocol above. The percentage of apoptosis
was computed using Cell Quest software (Becton Dickinson).
Chromatin Immunoprecipitation assay and Quantification of ChIP assay
ChIP assay was conducted with the ChIP assay kit essentially as described in the manufacturer
(Upstate). Detailed experimental procedures are described in our previous report article [25].
For quantitative analysis of ChIP products, real-time PCR was carried out according to
ROCHE manufacturer's instructions using SYBR Green real-time PCRMaster Mix. Primers
designed for specifically amplifying NOXA-SBS1, BCL2-SBS1 and mbr of BCL2 were listed in
supporting information: S1 Table. Standard curves for relative quantification were calculated
using 1:4, 1:16, 1:64, and 1:256 dilutions of input samples. All PCR signals from immno-precip-
itation samples were referred to their respective input standard curve to normalize differences
in cell number and primer efficiency. Real-time PCR datas were analyzed according to the
methodology described in a report. ΔCt values were first calculated using the formula: ΔCt = Ct
(sample)–Ct (input), from which ΔΔCt (ΔCt experiment sample–ΔCt negative control) and
fold difference (2(–ΔΔCt treatment)/ 2(–ΔΔCt control) were derived.
Chromosome Conformation Capture (3C)
The 3C protocol was adapted from published article with modifications. Detailed experimental
procedures are described in our previous article [25]. Quantitative real-time PCR was per-
formed, in the presence of SYBR Green, with appropriate primers from purified DNA as well
as the control template. To accurately determine the DNA concentration of a 3C sample,
20-dilutions of each 3C sample was first analyzed by real-time PCR using ChIP BCL2-SBS1
primers and the DNA concentration was calculated according to the standard curve that was
established using reference genomic DNA with known concentration. Samples were then sub-
sequently adjusted to a concentration of 50ng/μl. For each primer pair successive 4-fold
(PGK1) or 2-fold dilutions of the random ligation standard were used to make a calibration
curve for determining a relative quantity of the corresponding ligation product in a 3C sample.
The ligation efficiency between the samples were corrected by the interaction between two Ase
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I fragments orHind III fragments within the ubiquitously expressed PGK1 locus that had been
checked to be transcribed stably in our experiment systems.
Results
1. SATB1 bound to the promoters of both NOXA and BCL2 genes and
mbr enhancer.
We have demonstrated that the SATB1-mediated long-range chromatin interaction between
the mbr enhancer and BCL2 promoter is critical to regulating BCL2 expression in the cellular
apoptotic response [25]. To investigate whether SATB1-mediated long-range chromatin inter-
action is involved in co-regulation of anti-apoptotic and pro-apoptotic genes, we used Geno-
matix Software (Genomatix Software, http://www.genomatix.de/index.html) to analyze the
promoter regions of Bcl2 family members for the binding sites of SATB1). The NOXA gene
located 3.4Mb downstream of the BCL2 gene was of particular interest. NOXA has 3 sequences
that are possible SATB1 binding sites. These sequences are NOXA-SBS1 to NOXA-SBS3, and
are located within the 3.5kb region upstream of the NOXA transcription start site. The illustra-
tions of three SATB1 binding sites in NOXA promoter have been shown in Fig 1. We used
ChIP assays with the anti-SATB1 antibody to test SATB1 binding on the NOXA promoter.
NOXA-SBS1 sequence located 2.4kb relative to the translational start site were found to be spe-
cifically immunoprecipitated with anti-SATB1 (Fig 2), indicating that SATB1 binds to this
sequence in vivo. The precipitated products were weak for SBS2. No specific precipitate was
detected for SBS3 (Fig 2). As expected and confirmed in our previous work, SATB1 also bound
to the mbr enhancer (Fig 2). Given that SATB1 is a critical factor in regulating long-range
interactions between the mbr and BCL2 promoter [25], the binding of SATB1 to the NOXA
promoter strongly suggested that SATB1 not only mediated an interaction between the mbr
and the BCL2 promoter, but also was involved in the mbr-NOXA chromatin interaction.
2. The promoters of both NOXA and BCL2 genes interacted with the mbr
enhancer through chromatin loop structures.
Then, we investigated whether NOXA promoter participated in promoter-mbr higher-order
chromatin loop structure using a 3C assay, which is able to indicate whether two remote geno-
mic sequences interact in the nucleus. The PCR products derived from the 3C library showed
that the NOXA gene promoter juxtaposed with the mbr enhancer and BCL2 gene promoter
(Fig 2). The specificity of the PCR products was validated by DNA sequencing (Supporting
information: S1 and S2 Figs). These results indicated that the promoter of NOXA physically
interacted with the mbr enhancer over 3.4Mb and might form a promoter-promoter-mbr com-
plex with the BCL2 promoter and the mbr enhancer in nucleus through higher-order chroma-
tin structures.
3. SATB1 level was critical for the chromatin loop conversion and the
cooperative expression of the BCL2 and NOXA genes.
To clarify whether SATB1 was involved in the cooperative regulation of NOXA and BCL2
expression by changing higher-order chromatin structure, we examined the correlation
between the SATB1 binding on the gene promoters and mbr enhancer and the frequency of
mbr-NOXA and mbr-BCL2 chromatin loops. The expression of SATB1 was knocked down in
Jurkat cells with plasmids expressing short hairpin RNAs (shRNA). Targeting efficiency was
confirmed by Western blot analysis (Fig 3). The effects of SATB1 knockdown were determined
by quantitative ChIP assay (q-ChIP). As indicated in Fig 3, SATB1 knockdown significantly
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reduced the occupation of SATB1 on NOXA promoter. The knockdown-induced reduction of
SATB1 binding on the BCL2 promoter region and the mbr enhancer was confirmed (Fig 3).
Notably, the reduced SATB1 binding significantly increased mbr-NOXA interactions, while
dramatically decreased the mbr-BCL2 interactions (Fig 3), indicating that SATB1 was involved
in the dynamic conversion between the mbr-BCL2 chromatin loop and the mbr-NOXA chro-
matin loop. Under the same experimental conditions, the transcriptional activities of the BCL2
and NOXA genes were determined by real-time PCR. Our data showed that the change in
BCL2 and NOXAmRNA levels kept pace with the conversion of the mbr-promoter loops (Fig
3), indicating that SATB1-mediated mbr-promoter interactions were required for BCL2 and
NOXA transcriptional activity. These results suggested that SATB1 was an important determi-
nant for conversion between the mbr-BCL2 chromatin loop and the NOXA chromatin loop,
and was involved in cooperative regulation of BCL2 and NOXA gene expression.
Fig 1. ChIP analysis of SATB1 binding on the NOXA promoter region and the mbr element in vivo. Diagram shows the relative positions of three
SATB1 binding sites(N-SBS1、N-SBS2、N-SBS3) in NOXA promoter region and mbr(A). The results showed that NOXA-SBS1 sequence located 2.4kb
relative to the translational start site were specifically immunoprecipitated with anti-SATB1 (B, indicating that SATB1 binds to this sequence in vivo. The
SATB1 binding to SBS2 was very weak (C. No SATB1 binding to SBS3 was detected (D. As confirmed earlier, SATB1 bound to the mbr (E). The input
represented 1% of total DNA used in immunoprecipitation. Non-specific IgG was used as a negative control. The PCR products were visualized by ethidium
bromide staining of a 1.5% agarose gel.
doi:10.1371/journal.pone.0139170.g001
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4. SATB1 regulated the cooperative response of the BCL2 and NOXA
genes to apoptosis stimulation by switching the mbr-BCL2 chromatin
loop to the mbr-NOXA chromatin loop.
Apoptosis is a biological process tightly regulated by the pro-apoptotic and anti-apoptotic pro-
teins. To address whether the SATB1-mediated chromatin loop conversion was involved in
regulation of the cooperative response of the BCL2 and NOXA genes to apoptosis stimulation,
we analyzed the change in chromatin loops, transcriptional activity of the genes, and SATB1
level in Jurkat cells treated with camptothecin. Cells were incubated with 5μM camptothecin
and harvested after 2 h, when early apoptosis occurred and SATB1 was degraded to 70%. (Fig
4). The chromatin loop conversion was determined by quantitative 3C assays (q-3C). As indi-
cated in Fig 4, the frequency of interaction between the BCL2 promoter and mbr (mbr-BCL2
chromatin loop) was significantly reduced, while the frequency of interaction between the
NOXA promoter and mbr (mbr-NOXA chromatin loop) was increased in camptothecin-
treated cells. Consistently, real-time PCR results showed that camptothecin treatment induced
opposite changes in mRNA levels of the BCL2 and NOXA genes. The BCL2 mRNA decreased
Fig 2. 3C assays to detect physical interactions of the mbr-NOXA and NOXA-BCL2. Diagram shows the relative positions of the BCL2 gene, NOXA
gene, and mbr element in chromosome 18(A). Physical interactions of the mbr-NOXA (B, upper panel) and NOXA-BCL2 (C, upper panel) genes were
identified by PCRs which detected hybrid fragments with specific primers. PCR products from HindIII-digested crosslinked chromatin without ligation and
non-crosslinked genomic DNA, with or without ligation, were used as negative controls. We used the PCR products from genomic DNA that was not cut by
any restriction enzyme as the loading controls (B & C, lower panels).
doi:10.1371/journal.pone.0139170.g002
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by 50%, while the NOXAmRNA increased by approximately two folds (Fig 4). These data indi-
cated that the.SATB1-mediated conversion between the mbr-BCL2 chromatin loop and the
mbr-NOXA chromatin loop was directly involved in the coordinated regulation of the BCL2
and NOXA genes in the cellular apoptotic response.
SATB1 is the target of caspase-6 and is specifically cleaved by this enzyme during early apo-
ptosis. In order to determine the specificity of the SATB1 function in the cooperative regulation
of the BCL2 and NOXA genes during apoptosis, we examined the effects of inhibiting SATB1
degradation on BCL2 and NOXA transcriptional activity. Jurkat cells were pretreated for 30
min with 10 μMZ-VEID-fmk, a caspase-6 inhibitor, before the addition of camptothecin.
Western blot analysis showed that pretreatment of cells with 10 μMZ-VEID-fmk completely
inhibited camptothecin-induced cleavage of SATB1 (Fig 5). As expected, inhibition of SATB1
degradation reversed the mRNA levels of both BCL2 and NOXA in these cells (Fig 5), signifi-
cantly suppressing apoptosis (Fig 5). The specificity of SATB1 function was further evaluated
by an experiment using a mutant SATB1 expression vector that was resistant to caspase-6
cleavage. Jurkat cells were transfected with a wild-type SATB1 expression vector (EGFP-
SATB1), a mutant SATB1 expression vector (EGFP-SATB1-D254A), or a pEGFP-C1 control
vector before treatment with camptothecin. The transfection efficiency was examined by
Fig 3. SATB1 was a critical factor for the chromatin loop conversion and the cooperative expression of BCL2 and NOXA genes in Jurkat cells.
Jurkat cells were transiently transfected with control-shRNA or SATB1-shRNA plasmids, and targeting efficiency was confirmed byWestern blot analysis (A).
SATB1 knockdown significantly reduced the association of SATB1 with NOXA promoter (B), BCL2 promoter (C), and mbr (D), as revealed by q-ChIP.
Quantitative 3C assays further showed that reduction of SATB1 binding significantly increased mbr-NOXA interactions and dramatically decreased the mbr-
BCL2 interactions (E). RT–PCR analysis confirmed the BCL2 mRNA level was decreased while the NOXAmRNA level was increased, keeping pace with the
conversion of the mbr-promoter loops; we normalized all the genes by using actin control for quantity. (F). These results indicated that reduced SATB1
switched the mbr-BCL2 chromatin loop to the mbr-NOXA chromatin loop, which was involved in cooperative regulation of the NOXA and BCL2 genes.
doi:10.1371/journal.pone.0139170.g003
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Western blot (Fig 5). As expected, overexpression of the mutant undegradable SATB1 almost
completely reversed changes in expression levels of the BCL2 and NOXA mRNA in Jurkat cells
treated with camptothecin, while overexpression of the wild-type SATB1 had only slight effects
on the mRNA levels of these two genes under the same experimental conditions (Fig 5). These
data clearly demonstrated that SATB1 plays a specific role in regulating the cooperative
response of the BCL2 and NOXA genes to apoptotic stimulation.
Discussion
Our previous studies demonstrate that SATB1 enhances BCL2 transcription by establishing
chromatin loop architecture and recruiting cofactors to form an active transcriptional complex
[25]. SATB1-mediated long-range chromosomal interaction between the mbr enhancer and
BCL2 promoter is indispensable for high transcriptional activity of the BCL2 promoter[23]
[24]. In the present study, we further investigated the function of SATB1-mediated higher-
order chromatin structure in the cooperative regulation of the anti-apoptotic BCL2 gene and
Fig 4. SATB1-induced chromatin loop conversion in the co-regulation of the BCL2 and NOXA genes in cellular response to apoptosis. Jurkat cells
were treated with 5μM camptothecin for 2 h to induce apoptosis, and were subsequently harvested. The vehicle control for camptothecin is an equal volume
of DMSO. The apoptosis rates were determined by FCM (A) and the degradation of SATB1 was confirmed byWestern blot analysis (B). The distal chromatin
interactions and gene transcriptional activities were determined by q-3C assays and real-time PCR. The frequency of mbr-BCL2 chromatin loop was
significantly reduced, while the frequency of mbr-NOXA chromatin loop was increased in camptothecin-treated cells (C). These findings were coupled with
opposite changes in mRNA levels of the BCL2 and NOXA genes (D). These results, together with those described above, suggested that SATB1 was able to
co-regulate expression of the BCL2 and NOXA genes at the high-order chromatin structure level.
doi:10.1371/journal.pone.0139170.g004
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Fig 5. The specificity of SATB1 functions in co-regulating the expression of the BCL2 and NOXA genes in the cellular response to apoptosis. Cells
were pre-incubated with 10μM Z-VEID-fmk, a specific inhibitor of caspase-6, for 30 min, before camptothecin treatment to inhibit SATB1 degradation. SATB1
levels were determined byWestern blot (A). RT–PCR analysis revealed that inhibition of SATB1 degradation reversed the mRNA levels of both BCL2 and
NOXA in camptothecin-treated cells (B & C), and significantly suppressed apoptosis (D & E). The specificity of SATB1 function was further confirmed by the
expression of mutant SATB1 that was resistant to caspase-6 cleavage. Jurkat cells were transiently transfected with the pEGFP-C1 control vector、wild-type
SATB1-Mediated Chromatin Looping Co-Regulated the BCL2 andNOXAGenes
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the pro-apoptotic NOXA gene. Our data showed that the mbr enhancer targeted the NOXA
gene located 3.4Mb downstream of the BCL2 gene on chromosome 18.
The mbr enhancer, BCL2 promoter, and NOXA promoter were spatially tethered together
through SATB1-mediated chromatin loop structures. The SATB1-triggered chromatin conver-
sion regulated cooperative expression of the genes. The function of the chromatin conversion
was supported by negatively coupled changes in mbr-BCL2 chromatin looping and mbr-
NOXA chromatin looping that kept pace with the changes in the transcriptional activities of
these two genes, induced by the altered SATB1 levels. As indicated by our q-ChIP, q-3C, and
real-time PCR results, knocking down SATB1 expression with shRNA significantly reduced
the SATB1 binding on the mbr enhancer and gene promoters, and switched the BCL2 chroma-
tin loop to the NOXA chromatin loop. The decreased BCL2 chromatin looping and BCL2
expression were coupled with increased NOXA chromatin looping and NOXA expression. Our
results provide the first evidence that the two Bcl2 family members with antagonistic functions
share the same enhancer and were co-regulated through SATB1-induced higher-order chro-
matin conformation conversion.
SATB1 was not the only protein responsible for the re-organization of the BCL2 and NOXA
chromatin loops, although it was critical for maintaining the BCL2 chromatin loop and the
“mbr-BCL2-NOXA” chromatin structure/complex. It is still unclear why this looping not sus-
ceptible to SATB1 degradation and how the mbr and NOXA promoter were further tethered
and maintained when the SATB1/SATB1 protein complex departed from the bases of the chro-
matin loops and the mbr-BCL2 chromatin loop was disassembled. New protein(s) must partic-
ipate in further tethering the mbr-NOXA interaction and maintain the NOXA chromatin loop
at higher levels after the departure of the SATB1/SATB1 complex. We propose that a potential
candidate protein might be a transcription factor that could function as chromatin organizer
by forming protein polymers and recruiting other transcription factors and cofactors to the
binding sites. A spectrum of MAR-binding proteins, including Cux/CDP [27], SAF-A [28],
Bright [29], SATB1 [30], and SATB2 [31] have been found to participate in the regulation of
chromatin structure and gene transcription. It will be informative to investigate the roles of
these MAR-binding proteins, especially the SATB1 homolog SATB2, in the co-regulation of
the NOXA and BCL2 genes and other Bcl2 family members. CDP, a homeodomain protein of
SATB1 that has a DNA-binding domain similar to SATB1 and competes with SATB1 to bind
with specific DNA sequences [32], may be an especially promising candidate for the reorgani-
zation of the BCL2 and NOXA chromatin loops. Clarifying the functions of CDP and other
possible candidate proteins in the chromatin conversion will provide insight into the rules gov-
erning apoptotic-stimulus-responsive dynamic changes in higher-order chromatin structures
and their relationship to co-regulation of genes. It is also interesting that NOXA is looped with
the mbr-enhancer in absence of apotosis. Although NOXA is a typical pro-apoptotic protein
and plays an important role in regulation of apoptosis, NOXA expression can be detected
under normal culture condition in the cell model we used, indicating the baseline NOXA
expression is required for cell activity in absence of apoptosis. We speculate that the SATB1-
mediated looping of NOXA with the mbr enhancer is required for keeping the baseline NOXA
SATB1 expression vector (pEGFP-C1- SATB1), and mutant SATB1 expression vector, respectively, and treated with 5μM camptothecin for 2h to induce
apoptosis 24 hours after transfection. SATB1 expression levels were determined byWestern blot analysis, which showed that the expression level of mutant
SATB1 was consistent in camptothecin-treated cells, and wild-type SATB1 was decreased (F). RT–PCR analysis showed that overexpression of mutant
SATB1 completely restored BCL2 expression and inhibited the increase in NOXA expression, and overexpression of the wild-type SATB1 partly reversed
mRNA levels of these two genes (G, H). The statistical differences were calculated using t-test. ‘**’ Represents P<0.01. The error bars represent standard
deviation (n = 3).
doi:10.1371/journal.pone.0139170.g005
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expression. Furthermore, the NOXA-mbr looping may provide a ready state which is helpful
for the high expression of NOXA in cellular response to apoptosis stimulation.
The cooperative regulation of the BCL2 and NOXA genes by SATB1 at higher-order chro-
matin structure levels is significant in view of the profound association of SATB1 with cancer
development and chemotherapy resistance [14,16]. In the present study, we carefully evaluated
the biological significance of the SATB1-mediated chromatin loop conversion in apoptosis in
Jurkat cells. SATB1 is known to be the target of caspase-6 [33]. We demonstrated that SATB1
cleavage at an early stage of apoptosis switched the BCL2 chromatin loop structure toward
NOXA chromatin loop structure by modulating the association of SATB1 with the mbr and
the two promoters. Consequently, BCL2 transcription was dramatically down regulated and
NOXA transcription was up regulated.
It is important to point out that the role of SATB1 was specific, since transfection of cells
with mutant SATB1 that were resistant to caspase-6 or treatment with caspase-6 inhibitor
restored BCL-2 expression and reduced NOXA levels in Jurkat cells treated with camptothecin,
and thus significantly suppressed apoptosis. Therefore, the SATB1 level profoundly influenced
cell fate by co-regulating expression of the anti-apoptotic BCL2 gene and the pro-apoptotic
NOXA gene during the cellular response to apoptosis. Recent studies have shown that many
types of cancer cells aberrantly express SATB1 [9], which is positively correlated with poor
prognosis and pathological properties [34,35]. The underlying mechanism is still unclear. Our
data led us to infer that such aberrant SATB1 expression might endow cells with excess ability
to resist apoptosis by maintaining the higher-order chromatin structure in favor of the expres-
sion of anti-apoptotic genes such as the BCL2 gene, thus suppressing pro-apoptotic genes, and
consequently providing the cancer cells with selective advantages.
Genome-wide investigation of chromatin interaction and the interactome has revealed
widespread stimulus-responsive promoter-promoter and promoter-enhancer interactions
between co-regulated genes. This suggests the role of such a “multi-gene complex” in providing
a topological framework for the transcription of co-regulated genes [36]. The intrinsic pathway
of apoptosis is governed by the balance between opposing factions of the Bcl2 protein family
that consists of pro-survival proteins and pro-apoptotic proteins. However, little is known
about the function of higher-order chromatin structures in governing the balance of Bcl2 fam-
ily members, although multiple transcriptional factors like CREB, ER alpha, and p53 [37–39]
have been described to specifically regulate expression of this gene family and contribute to the
control of the apoptosis pathway. The present study uncovered a novel mechanism with strong
evidence that the BCL2 and NOXA genes were cooperatively regulated through SATB1-in-
duced chromatin loop conversion, despite the antagonistic functions of these two genes. This
finding suggests that different Bcl2 family members and other functionally related genes might
be organized into one or more related frameworks by SATB1 or other transcription factors at
higher-order chromatin structure levels, in order for their cooperative expression to regulate
apoptosis. The mbr enhancer might be an important node of this framework. Further investi-
gations combining 4C and high throughput techniques, such as ChIP-PET, to identify more
SATB1-mediated mbr-promoter interactions and promoter-promoter interactions will provide
new opportunities for clarifying how apoptosis is disrupted in cancer cells. In summary, our
present study uncovered a novel mechanism of how the anti-apoptotic BCL2 and pro-apopto-
tic NOXA genes were cooperatively expressed by SATB1 at higher-order chromatin structure
levels. Our work provides a valuable model for the investigation of SATB1-mediated long-
range chromatin interactions in regulating the dynamic equilibrium of apoptosis-controlling
genes with antagonistic functions.
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Supporting Information
S1 Fig. The specificity of the PCR product generated by 3C technology designed to detect
mbr and NOXA promoter interaction was validated by DNA sequencing.
(TIFF)
S2 Fig. The specificity of the PCR product generated by 3C technology designed to detect
BCL2 and NOXA promoters interaction was validated by DNA sequencing.
(TIFF)
S3 Fig. 3C Analysis of the interaction between the mbr and the NOXA-1/NOXA-2 in vivo.
The scheme of NOXA gene with the positions of restriction sites and positions of primers were
indicated in A. The three SATB1 binding sites as been showed as N-SBS1、N-SBS2 and
N-SBS3 (A). The 3C experiments were performed as described in the ‘Materials and Methods’
section. Physical interactions between mbr and NOXA-1/NOXA-2 were then determined by
specific PCRs that detected hybrid fragments containing either mbr sequences or NOXA-1/
NOXA-2 sequences. 3C data demonstrated that the mbr specifically interacted with NOXA-1
(B, upper panel), but not with NOXA-2 (B, middle panel). PCR products from HindIII digested
cross-linked chromatin without ligation and non-crosslinked genomic DNA with or without
ligation were used as negative controls. The bands shown in the bottom panels of B represented
the PCR products from genomic DNA that was not cut by any restriction enzyme, which were
used as the loading control. The bands shown in C are PCR products from BAC plasmids that
showed the primers for 3C experiments are pretty good.
(TIFF)
S4 Fig. The specificity of the PCR product generated by 3C technology designed to detect
NOXA promoter downstream region and mbr interaction was validated by DNA sequenc-
ing.
(TIFF)
S5 Fig. The SATB1 expression level in the stimulation of camptothecin. (A)Western blot
determined SATB1 expression level in Jurkat cells treated with camptothecin for three trials. (B)
Gray analysis of SATB1 expression level in the stimulation of camptothecin showed SATB1
degraded to 70%. (C) SATB1 mRNA level decreased to 50% in the stimulation of camptothecin.
(TIFF)
S1 Table. All the primers used in this article.
(PDF)
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